TONIX PHARMACEUTICALS HOLDING CORP. Long-Term Debt
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) had Long-Term Debt of $4.67 million as of 2024-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-03-12
- 2024-12-31: Long-term Debt, Excluding Current Maturities $4.67M.
- 2024-09-30: Long-term Debt, Excluding Current Maturities $5.17M.
- 2024-06-30: Long-term Debt, Excluding Current Maturities $5.67M.
- 2024-03-31: Long-term Debt, Excluding Current Maturities $6.16M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2024-12-31 | $4.67M 10-K · filed 2026-03-12 |
| 2024-09-30 | $5.17M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $5.67M 10-Q · filed 2024-08-16 |
| 2024-03-31 | $6.16M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $6.56M 10-K · filed 2025-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |